Adjuvant chemotherapy in early-stage colon cancer may improve survival

Researchers and physicians have grappled with the role of ‘adjuvant,’ or post-surgery, chemotherapy for patients with early-stage colon cancer, even for cancers considered high risk. Now researchers have found an association between the use of adjuvant chemotherapy in stage 2 colon cancer and improved survival — regardless of a patient’s age or risk, or even of the specific chemotherapy administered.